<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="abstract"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Eur Psychiatry</journal-id><journal-id journal-id-type="iso-abbrev">Eur Psychiatry</journal-id><journal-id journal-id-type="publisher-id">EPA</journal-id><journal-title-group><journal-title>European Psychiatry</journal-title></journal-title-group><issn pub-type="ppub">0924-9338</issn><issn pub-type="epub">1778-3585</issn><publisher><publisher-name>Cambridge University Press</publisher-name><publisher-loc>Cambridge, UK</publisher-loc></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmc">PMC11859394</article-id><article-id pub-id-type="doi">10.1192/j.eurpsy.2024.299</article-id><article-id pub-id-type="other">EPP0070</article-id><article-id pub-id-type="pii">S0924933824002992</article-id><article-categories><subj-group subj-group-type="heading"><subject>Abstract</subject></subj-group><subj-group subj-group-type="section"><subject>e-Poster Presentation</subject></subj-group></article-categories><title-group><article-title>Birth weight, leptin and adiponectin in patients initiating clozapine</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name><surname>Ilzarbe</surname><given-names>L.</given-names></name><xref rid="aff0573" ref-type="aff">
<sup>1</sup></xref><xref rid="aff0574" ref-type="aff">
<sup>2</sup></xref><xref rid="cor0160" ref-type="corresp">
<sup>*</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Garriga</surname><given-names>M.</given-names></name><xref rid="aff0573" ref-type="aff">
<sup>1</sup></xref><xref rid="aff0574" ref-type="aff">
<sup>2</sup></xref><xref rid="aff0575" ref-type="aff">
<sup>3</sup></xref></contrib><contrib contrib-type="author"><name><surname>Oliveira</surname><given-names>C.</given-names></name><xref rid="aff0576" ref-type="aff">
<sup>4</sup></xref></contrib><contrib contrib-type="author"><name><surname>G&#x000f3;mez-Ramiro</surname><given-names>M.</given-names></name><xref rid="aff0574" ref-type="aff">
<sup>2</sup></xref><xref rid="aff0575" ref-type="aff">
<sup>3</sup></xref><xref rid="aff0577" ref-type="aff">
<sup>5</sup></xref></contrib><contrib contrib-type="author"><name><surname>Mallorqu&#x000ed;</surname><given-names>A.</given-names></name><xref rid="aff0578" ref-type="aff">
<sup>6</sup></xref></contrib><contrib contrib-type="author"><name><surname>Ruiz-Cort&#x000e9;s</surname><given-names>V.</given-names></name><xref rid="aff0578" ref-type="aff">
<sup>6</sup></xref></contrib><contrib contrib-type="author"><name><surname>Rivas</surname><given-names>Y.</given-names></name><xref rid="aff0578" ref-type="aff">
<sup>6</sup></xref></contrib><contrib contrib-type="author"><name><surname>Amoretti</surname><given-names>S.</given-names></name><xref rid="aff0574" ref-type="aff">
<sup>2</sup></xref><xref rid="aff0575" ref-type="aff">
<sup>3</sup></xref><xref rid="aff0579" ref-type="aff">
<sup>7</sup></xref><xref rid="aff0580" ref-type="aff">
<sup>8</sup></xref></contrib><contrib contrib-type="author"><name><surname>Mezquida</surname><given-names>G.</given-names></name><xref rid="aff0574" ref-type="aff">
<sup>2</sup></xref><xref rid="aff0575" ref-type="aff">
<sup>3</sup></xref><xref rid="aff0579" ref-type="aff">
<sup>7</sup></xref><xref rid="aff0581" ref-type="aff">
<sup>9</sup></xref></contrib><contrib contrib-type="author"><name><surname>Ilzarbe</surname><given-names>D.</given-names></name><xref rid="aff0574" ref-type="aff">
<sup>2</sup></xref><xref rid="aff0575" ref-type="aff">
<sup>3</sup></xref><xref rid="aff0582" ref-type="aff">
<sup>10</sup></xref></contrib><contrib contrib-type="author"><name><surname>Vieta</surname><given-names>E.</given-names></name><xref rid="aff0573" ref-type="aff">
<sup>1</sup></xref><xref rid="aff0574" ref-type="aff">
<sup>2</sup></xref><xref rid="aff0575" ref-type="aff">
<sup>3</sup></xref></contrib><contrib contrib-type="author"><name><surname>Parellada</surname><given-names>E.</given-names></name><xref rid="aff0574" ref-type="aff">
<sup>2</sup></xref><xref rid="aff0575" ref-type="aff">
<sup>3</sup></xref><xref rid="aff0579" ref-type="aff">
<sup>7</sup></xref></contrib><contrib contrib-type="author"><name><surname>Baeza</surname><given-names>I.</given-names></name><xref rid="aff0574" ref-type="aff">
<sup>2</sup></xref><xref rid="aff0575" ref-type="aff">
<sup>3</sup></xref><xref rid="aff0579" ref-type="aff">
<sup>7</sup></xref><xref rid="aff0582" ref-type="aff">
<sup>10</sup></xref></contrib><contrib contrib-type="author"><name><surname>Garc&#x000ed;a-Rizo</surname><given-names>C.</given-names></name><xref rid="aff0574" ref-type="aff">
<sup>2</sup></xref><xref rid="aff0575" ref-type="aff">
<sup>3</sup></xref><xref rid="aff0579" ref-type="aff">
<sup>7</sup></xref></contrib></contrib-group><aff id="aff0573">
<sup>1</sup><institution>Bipolar and Depressive Disorders Unit, Hospital Clinic, Institute of Neuroscience, University of Barcelona</institution></aff><aff id="aff0574">
<sup>2</sup><institution>Institut d&#x02019;investigacions Biom&#x000e8;diques August Pi i Sunyer (IDIBAPS)</institution></aff><aff id="aff0575">
<sup>3</sup><institution>Centro de Investigaci&#x000f3;n Biom&#x000e9;dica en Red de Salud Mental (CIBERSAM)</institution>, Instituto de Salud Carlos III, <city>Barcelona</city>, <country>Spain</country></aff><aff id="aff0576">
<sup>4</sup><institution>University of Coimbra</institution>, <city>Coimbra</city>, <country>Portugal</country></aff><aff id="aff0577">
<sup>5</sup>Hospital Alvaro Cunqueiro, SERGAS, <institution>Translational Neuroscience Research Group, Galicia Sur Health Research Institute (IISGS)</institution>, <city>Vigo</city></aff><aff id="aff0578">
<sup>6</sup>Department of Psychiatry, <institution>Institute of Neuroscience, Hospital Clinic Barcelona, University of Barcelona</institution></aff><aff id="aff0579">
<sup>7</sup>Barcelona Clinic Schizophrenia Unit, Hospital Clinic of Barcelona, Hospital Clinic, Institute of Neuroscience, <institution>University of Barcelona</institution></aff><aff id="aff0580">
<sup>8</sup>Group of Psychiatry, Mental Health and Addictions, <institution>Vall d&#x02019;Hebron Research Institute (VHIR), Psychiatric Genetics Unit, Vall d&#x02019;Hebron Research Institute (VHIR)</institution></aff><aff id="aff0581">
<sup>9</sup>Department of Basic Clinical Practice, Pharmacology Unit, <institution>University of Barcelona</institution></aff><aff id="aff0582">
<sup>10</sup>Child and Adolescent Psychiatry and Psychology Department, 2021SGR01319, <institution>Institute Clinic of Neurosciences, Hospital Cl&#x000ed;nic of Barcelona</institution>, <city>Barcelona</city>, <country>Spain</country></aff><author-notes><corresp id="cor0160"><label>*</label>Corresponding author.</corresp></author-notes><pub-date publication-format="electronic" date-type="collection" iso-8601-date="2024-04"><month>4</month><year>2024</year></pub-date><pub-date pub-type="epub"><day>27</day><month>8</month><year>2024</year></pub-date><volume>67</volume><issue seq="274">Suppl 1</issue><issue-title content-type="special_issue">Abstracts of the 32nd European Congress of Psychiatry</issue-title><fpage>S128</fpage><lpage>S129</lpage><permissions><copyright-statement>&#x000a9; The Author(s) 2024</copyright-statement><copyright-year>2024</copyright-year><copyright-holder>The Author(s)</copyright-holder><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (<uri xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</uri>), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><self-uri xlink:title="pdf" xlink:href="S0924933824002992a.pdf"/><abstract><sec id="sec0960"><title>Introduction</title><p>Psychotic patients often require pharmacological treatment, which may prove ineffective, leading to treatment-resistant psychosis necessitating the use of clozapine. However, the emergence of side effects can result in discontinuation, potentially triggering a relapse of psychotic symptoms. One significant side effect is antipsychotic-induced weight gain which, over time, can lead to adverse metabolic events. Recent translational research is evaluating the impact of prenatal factors on the metabolic outcomes of psychotic patients, using a surrogate marker of the intrauterine milieu such as birth weight (BW).</p></sec><sec id="sec0961"><title>Objectives</title><p>We aim to evaluate the changes in leptin, adiponectin, and insulin levels in patients with treatment-resistant psychosis who initiate clozapine treatment due to persistent psychotic symptoms.</p></sec><sec id="sec0962"><title>Methods</title><p>Subjects older than 18 years with a diagnostic of a major mental disorder and initiating clozapine were enrolled in this 18-months longitudinal study. Neurohormones levels, including leptin, adiponeptin, and insulin were measured at baseline, 8 and 18 months during follow-up. Statistical analysis were conducted by using a fixed-effects model.</p></sec><sec id="sec0963"><title>Results</title><p>A total of 23 subjects initiating clozapine were evaluated during the initial mandatory 18-week period. Neurohormones, specifically leptin and adiponectin, were measured at three time points: baseline, 8 weeks, and 18 weeks. The changes in leptin levels were significantly associated with birth BW with sex differences, being inversely correlated only in females. Adiponectin was significantly associated with BW, being inversely correlated in males. Conversely, there was no observed association between insulin levels and BW.</p></sec><sec id="sec0964"><title>Conclusions</title><p>Our findings highlight the significance of prenatal factors in influencing the subsequent evolution of neurohormones in individuals initiating clozapine treatment. This suggests that subjects with lower BW tend to exhibit elevated neurohormone values, emphasizing the role of prenatal events in this context.</p></sec><sec id="sec0965"><title>Disclosure of Interest</title><p>None Declared</p></sec></abstract><counts><page-count count="2"/></counts></article-meta></front></article>